|
US6770261B2
(en)
*
|
1995-06-02 |
2004-08-03 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the detection of physiological agents
|
|
US6713045B1
(en)
|
1995-06-02 |
2004-03-30 |
Research Corporation Technologies, Inc. |
Targeted magnetic resonance imaging agents for the detection of physiological processes
|
|
US5900228A
(en)
|
1996-07-31 |
1999-05-04 |
California Institute Of Technology |
Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
|
|
US6675035B1
(en)
*
|
1997-06-20 |
2004-01-06 |
Imaging Diagnostic Systems, Inc. |
Phantom for optical and magnetic resonance imaging quality control
|
|
CA2303426C
(en)
*
|
1997-10-02 |
2008-09-23 |
Epix Medical, Inc. |
Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
|
|
JP2001521011A
(ja)
*
|
1997-10-27 |
2001-11-06 |
カリフォルニア・インスティテュート・オブ・テクノロジー |
治療成分送達のための磁気共鳴イメージング剤
|
|
US6713046B1
(en)
|
1997-10-27 |
2004-03-30 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
EP1032430A2
(en)
|
1997-11-17 |
2000-09-06 |
Research Corporation Technologies, Inc. |
Magnetic resonance imaging agents for the detection of physiological agents
|
|
IT1297034B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
IT1297035B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
US6167297A
(en)
|
1999-05-05 |
2000-12-26 |
Benaron; David A. |
Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
|
|
US6230586B1
(en)
*
|
1999-05-21 |
2001-05-15 |
Chung-Hsi Chang |
Electric drive device for a bicycle
|
|
HK1048952A1
(zh)
|
1999-07-29 |
2003-04-25 |
埃匹克斯医学股份有限公司 |
通过多位点结合的寻靶多体造影剂
|
|
WO2001052906A2
(en)
*
|
2000-01-22 |
2001-07-26 |
Epix Medical, Inc. |
Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzymatic cleavage
|
|
US6656448B1
(en)
*
|
2000-02-15 |
2003-12-02 |
Bristol-Myers Squibb Pharma Company |
Matrix metalloproteinase inhibitors
|
|
US20040146463A1
(en)
*
|
2000-05-04 |
2004-07-29 |
Meade Thomas J. |
Functional MRI agents for cancer imaging
|
|
US6673333B1
(en)
*
|
2000-05-04 |
2004-01-06 |
Research Corporation Technologies, Inc. |
Functional MRI agents for cancer imaging
|
|
AU2001259575A1
(en)
*
|
2000-05-04 |
2001-11-12 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
WO2001089584A2
(en)
*
|
2000-05-23 |
2001-11-29 |
Amersham Health As |
Contrast agents
|
|
US6748259B1
(en)
|
2000-06-15 |
2004-06-08 |
Spectros Corporation |
Optical imaging of induced signals in vivo under ambient light conditions
|
|
US6656450B2
(en)
|
2000-07-17 |
2003-12-02 |
California Institute Of Technology, Inc. |
Macrocyclic magnetic resonance imaging contrast agents
|
|
WO2002028441A2
(en)
|
2000-10-04 |
2002-04-11 |
California Institute Of Technology |
Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
|
|
US20030004236A1
(en)
*
|
2001-04-20 |
2003-01-02 |
Meade Thomas J. |
Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
|
|
WO2002087632A1
(en)
*
|
2001-05-02 |
2002-11-07 |
Metaprobe, Inc. |
High throughput screening methods using magnetic resonance imaging agents
|
|
TWI221406B
(en)
|
2001-07-30 |
2004-10-01 |
Epix Medical Inc |
Systems and methods for targeted magnetic resonance imaging of the vascular system
|
|
SI2301587T1
(sl)
|
2002-03-01 |
2014-11-28 |
Dyax Corp. |
KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
|
|
US20050100963A1
(en)
|
2002-03-01 |
2005-05-12 |
Dyax Corporation |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
US20030198597A1
(en)
*
|
2002-04-22 |
2003-10-23 |
Meade Thomas J. |
Novel macrocyclic activatible magnetic resonance imaging contrast agents
|
|
WO2004009134A1
(en)
*
|
2002-07-22 |
2004-01-29 |
Bracco Imaging S.P.A. |
Procedures of cellular labelling with paramagnetic complexes for mri applications
|
|
US20050163821A1
(en)
*
|
2002-08-02 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting Biodegradable Stent and Delivery Means
|
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
|
AU2004217894B2
(en)
|
2003-03-03 |
2010-07-15 |
Bracco International B.V. |
Peptides that specifically bind HGF receptor (cMet) and uses thereof
|
|
AU2004264857B2
(en)
*
|
2003-07-09 |
2010-06-10 |
Sutter West Bay Hospitals |
Remote detection of substance delivery to cells
|
|
US20050106100A1
(en)
*
|
2003-09-03 |
2005-05-19 |
Harris Thomas D. |
Compounds containing matrix metalloproteinase substrates and methods of their use
|
|
WO2005057169A2
(en)
*
|
2003-12-05 |
2005-06-23 |
Trellis Bioscience, Inc. |
Homogeneous competition assays
|
|
NO20035683D0
(no)
*
|
2003-12-18 |
2003-12-18 |
Amersham Health As |
Optisk avbildning av prostatakreft
|
|
FR2868320B1
(fr)
*
|
2004-03-31 |
2007-11-02 |
Centre Nat Rech Scient Cnrse |
Agent de contraste pour l'imagerie par resonance magnetique
|
|
US20060204445A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Cell scaffold matrices with image contrast agents
|
|
WO2006099332A2
(en)
|
2005-03-11 |
2006-09-21 |
Wake Forest University Health Sciences |
Production of tissue engineered digits and limbs
|
|
US7531503B2
(en)
*
|
2005-03-11 |
2009-05-12 |
Wake Forest University Health Sciences |
Cell scaffold matrices with incorporated therapeutic agents
|
|
US8491457B2
(en)
*
|
2005-03-11 |
2013-07-23 |
Wake Forest University Health Services |
Tissue engineered blood vessels
|
|
US20060204539A1
(en)
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Electrospun cell matrices
|
|
WO2006099334A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Wake Forest University Health Sciences |
Production of tissue engineered heart valves
|
|
EP1743658A1
(en)
|
2005-07-14 |
2007-01-17 |
Schering Aktiengesellschaft |
Optical imaging of rheumatoid arthritis
|
|
US20070014721A1
(en)
*
|
2005-06-30 |
2007-01-18 |
Harris Thomas D |
Hydrazide conjugates as imaging agents
|
|
US9339559B2
(en)
*
|
2005-09-09 |
2016-05-17 |
Georgia State University Research Foundation, Inc. |
Targeted contrast agents and methods for targeting contrast agents
|
|
WO2007084264A2
(en)
*
|
2005-12-29 |
2007-07-26 |
Epix Pharmaceuticals, Inc. |
Methods for myocardial imaging
|
|
NZ583931A
(en)
|
2007-08-17 |
2012-06-29 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
JPWO2009054327A1
(ja)
*
|
2007-10-22 |
2011-03-03 |
財団法人大阪産業振興機構 |
Ｍｒｉ用プローブ
|
|
WO2010107832A1
(en)
|
2009-03-17 |
2010-09-23 |
Bracco Imaging Spa |
Lhrh-ii peptide analogs
|
|
WO2010121133A2
(en)
|
2009-04-17 |
2010-10-21 |
The General Hospital Corporation |
Multimodal imaging of fibrin
|
|
JP2012521352A
(ja)
|
2009-03-19 |
2012-09-13 |
ワイス・エルエルシー |
［２−（８，９−ジオキソ−２，６−ジアザビシクロ［５．２．０］ノナ−１（７）−エン−２−イル）エチル］ホスホン酸およびその前駆体を調製するための方法
|
|
JP2011026294A
(ja)
|
2009-06-26 |
2011-02-10 |
Canon Inc |
化合物
|
|
WO2011035140A1
(en)
|
2009-09-18 |
2011-03-24 |
Paka Pulmonary Pharmaceuticals, Inc. |
Methods and compositions for delivery of contrast moieties to the lungs
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
CN102188722A
(zh)
*
|
2010-03-18 |
2011-09-21 |
中国科学院福建物质结构研究所 |
一种含二价铁的磁共振成像造影剂
|
|
US8192429B2
(en)
|
2010-06-29 |
2012-06-05 |
Theravant, Inc. |
Abnormality eradication through resonance
|
|
WO2013009869A2
(en)
|
2011-07-11 |
2013-01-17 |
Integrated Diagnostics, Inc. |
Akt-specific capture agents, compositions, and methods of using and making
|
|
KR102057132B1
(ko)
|
2012-03-08 |
2019-12-18 |
토멘 메디칼 아게 |
염증성 조직을 진단하기 위한 치과적 용도의 츄잉검
|
|
WO2013131994A2
(en)
*
|
2012-03-08 |
2013-09-12 |
Thommen Medical Ag |
Coating for the diagnosis of inflammatory tissues in dental applications
|
|
EP3875082A1
(en)
|
2012-11-15 |
2021-09-08 |
Endocyte, Inc. |
Conjugates for treating diseases caused by psma expressing cells
|
|
TN2016000137A1
(en)
|
2013-10-18 |
2017-10-06 |
Deutsches Krebsforsch |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer.
|
|
US10092679B2
(en)
|
2013-10-18 |
2018-10-09 |
Wake Forest University Health Sciences |
Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
|
|
ES3013992T3
(en)
|
2013-11-14 |
2025-04-16 |
Endocyte Inc |
Compounds for positron emission tomography
|
|
WO2015171543A1
(en)
|
2014-05-05 |
2015-11-12 |
California Institute Of Technology |
Mutant akt-specific capture agents, compositions, and methods of using and making
|
|
US10471162B2
(en)
|
2014-06-20 |
2019-11-12 |
The General Hospital Corporation |
Collagen targeted imaging probes
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
EP3270951B1
(en)
|
2015-03-16 |
2020-09-09 |
California Institute of Technology |
Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
|
|
IL256833B2
(en)
|
2015-07-15 |
2025-07-01 |
California Inst Of Techn |
IL-17F-specific binding agents, compositions and methods of use and preparation
|
|
US20170319722A1
(en)
|
2016-04-04 |
2017-11-09 |
Indi Molecular, Inc. |
Cd8-specific capture agents, compositions, and methods of using and making
|
|
EP3519425B1
(en)
|
2016-09-29 |
2024-02-28 |
Indi Molecular, Inc. |
Compositions for detection, inhibition and imaging of indoleamine 2,3-dioxygenase 1 (ido1) and methods of making and using same
|
|
US11358982B2
(en)
|
2016-11-01 |
2022-06-14 |
Ohio State Innovation Foundation |
Methods for the iodination of biomolecules
|
|
JP2020517584A
(ja)
*
|
2017-04-27 |
2020-06-18 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
修飾ｍｒｉ造影剤およびその使用
|
|
EP3638687A1
(en)
|
2017-06-15 |
2020-04-22 |
Indi Molecular, Inc. |
Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
|
|
WO2019075213A1
(en)
*
|
2017-10-11 |
2019-04-18 |
Northwestern University |
HEPARIN CONJUGATED TO PEPTIDES BINDING TO COLLAGEN FOR TARGETING BIOLOGICAL AND SYNTHETIC FABRICS
|
|
CN108314695B
(zh)
*
|
2018-01-04 |
2020-06-16 |
南京邮电大学 |
一种异种双核金属配合物的制备及应用
|
|
WO2019204335A1
(en)
|
2018-04-17 |
2019-10-24 |
Endocyte, Inc. |
Methods of treating cancer
|
|
US11919972B2
(en)
|
2018-11-02 |
2024-03-05 |
Regeneron Pharmaceuticals, Inc. |
Peptide libraries with non-canonical amino acids
|
|
WO2020097531A1
(en)
|
2018-11-08 |
2020-05-14 |
Indi Molecular, Inc. |
Theranostic capture agents, compositions, and methods of using and making
|
|
WO2020186091A1
(en)
|
2019-03-12 |
2020-09-17 |
Indi Molecular, Inc. |
Cross-linked epitopes and methods of use thereof
|
|
US12201679B2
(en)
|
2019-04-05 |
2025-01-21 |
Institute For Systems Biology |
Epitope-targeted peptide immunostimulants
|
|
WO2020236969A1
(en)
|
2019-05-20 |
2020-11-26 |
Indi Molecular, Inc. |
Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1)
|
|
EP3972627A4
(en)
|
2019-05-20 |
2023-06-21 |
Endocyte, Inc. |
Methods for preparing psma conjugates
|
|
EP3972646A4
(en)
|
2019-05-20 |
2023-06-14 |
Ohio State Innovation Foundation |
Apohemoglobin-haptoglobin complexes and methods of using thereof
|
|
US11414460B2
(en)
|
2019-07-19 |
2022-08-16 |
Institute For Systems Biology |
KRAS-specific capture agents, compositions, and methods of making and using
|
|
CN112891566A
(zh)
*
|
2019-12-04 |
2021-06-04 |
中国科学院宁波工业技术研究院慈溪生物医学工程研究所 |
一种纳米材料及其制备方法和包含其的造影剂
|
|
BR112022022045A2
(pt)
|
2020-04-30 |
2023-01-10 |
Sairopa B V |
Anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao cd103 humano, um ou mais ácidos nucleicos, sistema de expressão, célula hospedeira, composição, métodos de produção de um anticorpo ou fragmento de ligação ao antígeno, para detectar a presença de cd103 em uma amostra biológica, para tratar ou prevenir uma condição mediada por sinalização de cd103 em um indivíduo em necessidade, para inibir a sinalização de cd103 em uma célula, para inibir a ligação de cd103 à e-caderina presente em uma célula, para retirar as células que expressam cd103 em um indivíduo, para tratar ou prevenir uma doença e agente de imageamento
|
|
US12209142B2
(en)
|
2020-05-29 |
2025-01-28 |
Institute For Systems Biology |
SARS-CoV-2 epitope-targeted peptide immunostimulants
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
CN120093699B
(zh)
*
|
2025-03-06 |
2025-11-14 |
浙江大学 |
用于定位并稳定动脉粥样硬化斑块的诊疗分子、纳米粒及其制备方法
|